Alban Muller International launches Metabolami ER, an innovation for the prevention of the metabolic syndrome (MetS) and for intestinal comfort.
It is a dry extract of pomegranate, concentrated and titrated in polyphenols (24% minimum).
Its efficacy is tested in vivo, in vitro and ex vivo.
It prevents the development of the MetS, condition predisposing to the risk of developing cardiovascular diseases and type-2 diabetes.
It was shown to help restore the lipid profile to its homeostatic level, in particular by significantly reducing total cholesterol level as well as LDL-cholesterol, triglycerides and free fatty acids in blood.
This preventive action is reinforced by an antioxidant and anti-inflammatory activity that protects the organism from oxidative stress and chronic inflammations linked to the MetS, and a bifidogenic activity stimulating the assimilation of polyphenols by the organism.
